BREAKING NEWS: Dow Adds Over 1,200 Points to Nab Record High, Weekly Gain
Toggle navigation
About Us
Who We Are
About Bernie Schaeffer
Our Newsroom
FAQ
Contact Us
Corrections
Ethics & Fact Checks Policy
Market News
Sign Up for Free Market Newsletters
Opening View
Midday Market Check
Market Recap
View All Free Subscriptions
Schaeffer's Volatility Scorecard
Featured Publication
From the Top
Monday Morning Outlook
Indicator of the Week
Editor's Picks
View All
Trading Analysis
Best & Worst Stocks
Earnings Preview
Investor Sentiment
Quantitative Analysis
Technical Analysis
VIX & Volatility
View All
Stock Options
Intraday Options Activity
Most Active Options
Trade Postmortems
Options Recommendations
View All
Trading Education
Strategies & Concepts
Expectational Analysis
View All
Market News
Buzz Stocks
Stocks on the Move
Analyst Update
5 Minute Market Rundown
Stock Market Podcasts
View All
Daily Market Newsletters
Opening View
Midday Market Check
Market Recap
View All
Trade Alerts
All Trading Services
Most Popular Services
Elite Trader
Quick-Hit Trader
Lightning Trader
Ultimate Trader
View All
Directional Trading
Options Under $5
Leverage
Weekly Options Trader
Event Trader
PowerTrend
Schaeffer's Players
Overnight Trader
View All
Advanced Trading Alerts
Wealthbuilder
Premium Trader
Hedge Hunter
Volatility Trader
Weekly Volatility Trader
View All
Weekend Alert
Weekend Player
Weekend Trader Alert
Expiration Week Countdown
Weekly Options Countdown
View All
Newsletter Trading Services
Master Portfolio
The Option Advisor
Schaeffer's Daily Bulletin
View All
Courses & Education
Getting Started with Options
View All
Options 101
Deals
Deal of the Week
Broker Center
Free Trial
Log-In
Search
content-search-index
Tag: hims
hims
5
SEARCH RESULTS FOR: "Tag: hims"
REFINE YOUR SEARCH
REFINE YOUR SEARCH:
RECENT
Last Month
(1)
ARTICLES/BLOGS
2026
(1)
2025
(13)
2024
(9)
CATEGORIES
5-Minute Market Rundown
(1)
Bernie's Content
(1)
Buzz Stocks
(11)
Earnings Preview
(2)
Editor's Pick
(2)
Intraday Option Activity
(5)
Investor Sentiment
(1)
Most Active Options Update
(2)
Options Recommendations
(4)
Quantitative Analysis
(3)
Stocks On the Move
(1)
Technical Analysis
(2)
Trade Postmortem
(1)
Trader Content
(1)
Telehealth Stock Popular With Bulls Despite Underperformance
https://www.schaeffersresearch.com/content/options/2026/01/26/telehealth-stock-popular-with-bulls-despite-underperformance
1/26/2026 3:16 PM
Hims & Hers Health Inc (NYSE:HIMS) shares are up 3.4% to trade at $30.60 at last glance. The equity has struggled of late, now carrying a 47.3% nine-month deficit after last week gapping to its lowes...
Wall Street Resumes Winning Ways on CPI, Earnings Optimism
https://www.schaeffersresearch.com/content/news/2025/10/24/wall-street-resumes-winning-ways-on-cpi-earnings-optimism
10/24/2025 12:35 PM
All three major benchmarks are on their way to weekly wins, but it was far from the smooth sailing investors have gotten accustomed to. This week was rife with choppy price action, as investors wr...
Telehealth Stock Could Rebound Off Long-Term Trendline
https://www.schaeffersresearch.com/content/options/2025/10/23/telehealth-stock-could-rebound-off-long-term-trendline
10/23/2025 12:14 PM
Telehealth stock Hims & Hers Health Inc (NYSE:HIMS) just suffered a steep pullback after President Donald Trump's said Novo Nordisk's (NVO) weight-loss and diabetes drugs, Wegovy and Ozempic,...
Telehealth Stock Looks Primed for a Short Squeeze
https://www.schaeffersresearch.com/content/options/2025/09/19/telehealth-stock-looks-primed-for-a-short-squeeze
9/19/2025 10:19 AM
Subscribers to Schaeffer's Weekend Trader options recommendation service received this HIMS commentary on Sunday night, along with a detailed options trade recommendation -- including complete entry a...
Novo Nordisk, Hims and Hers Shares Tumble on Severed Ties
https://www.schaeffersresearch.com/content/news/2025/06/23/novo-nordisk-hims-and-hers-shares-tumble-on-severed-ties
6/23/2025 10:55 AM
Novo Nordisk A/S (NYSE:NVO) stock is down 5.3% to trade at $69.90 at last check, after the drugmaker's obesity drug CagriSema showed no clear advantage over Eli Lilly's (LLY) Zepbound. The company a...
LOAD MORE
PEOPLE ALSO SEARCH FOR
AMZN
APP
asts
BYND
cava
CVNA
docs
hims
IBM
INTC
KO
LLY
LMT
MRNA
NFLX
NVO
ORCL
PG
rklb
SHAK
smr
soun
TDOC
VKTX